Skip to main content
. 2020 May 15;20(2):1021–1029. doi: 10.3892/etm.2020.8758

Figure 4.

Figure 4

Blocking of ICAM1 or CD11a attenuates the severity of MPTP-induced PD in mice. (A) Blocking of ICAM1 or CD11a increased the levels of TH+ cells at day 4 after MPTP injection. Mouse behaviour assessed by open field tests showed improved clinical presentation in those treated with ICAM1 or CD11a blockade at day 4 after MPTP injection, including (B) distance moved, (C) rears and (D) grooms. n=9. Experiments were performed in triplicate. **P<0.01 and ***P<0.001. ICAM1, intercellular adhesion molecule 1; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; TH, tyrosine hydroxylase; CTRL, control; α-ICAM1, anti-ICAM1 antibodies; α-CD11a, anti-CD11a antibodies.